Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024184
Filing Date
2021-02-16
Accepted
2021-02-16 16:33:08
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216840d27_sc13ga.htm SC 13G/A 44986
  Complete submission text file 0001104659-21-024184.txt   46539
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Subject) CIK: 0001556263 (see all company filings)

EIN.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89552 | Film No.: 21639387
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET, 7TH FLOOR NEW YORK NY 10016 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

EIN.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A